Lactobacillus crispatus CTV-05

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), University of Washington

Conditions

Bacterial VaginosisUrinary Tract Infections (UTI's)

Phase 2

LACTIN-V Study for Recurrent Bacterial Vaginosis

CompletedNCT02766023

National Institute of Allergy and Infectious Diseases (NIAID)Bacterial Vaginosis

Start: 2016-06-03End: 2019-02-11Updated: 2020-03-04

Lactobacillus Probiotic for Prevention of UTI

CompletedNCT03151967

University of WashingtonUrinary Tract Infections (UTI's)

Start: 2015-09-30End: 2017-04-05Updated: 2023-03-01

Related Papers

Vaginal microbe-binding antibody interactions with a <i>Lactobacillus crispatus</i> live biotherapeutic following treatment for bacterial vaginosis.

2026-09-01

Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis–associated bacteria rather than lactobacilli

Journal of Clinical Investigation2022-02-0342 citations

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

New England Journal of Medicine2020-05-13328 citations